Related Experiment Video
Updated: May 31, 2026

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
Published on: May 25, 2018
Increased RNA editing in children with cyanotic congenital heart disease
Sharon Borik1, Amos J Simon, Yael Nevo-Caspi
1Department of Pediatric Critical Care Medicine, Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel.
Insights
Children with cyanotic congenital heart disease (CHD) show higher A-to-I RNA editing rates and more complex surgical outcomes. This suggests RNA editing may impact recovery after cardiac surgery in these patients.
Area of Science:
- Molecular Biology
- Genetics
- Pediatric Cardiology
Background:
- Cyanotic congenital heart disease (CHD) involves chronic hypoxia, impacting gene expression.
- Inflammatory and cardiac genes in cyanotic infants undergo RNA editing, potentially influencing their perioperative course.
Purpose of the Study:
- To investigate altered RNA editing in pediatric cyanotic CHD patients.
- To determine if A-to-I RNA editing correlates with postoperative outcomes after cardiac surgery.
Main Methods:
- RNA extracted from blood samples of cyanotic and acyanotic pediatric patients pre- and postoperatively.
- A-to-I RNA editing analyzed via DNA sequencing of the MED13 gene.
- RNA expression of adenosine deaminase acting on RNA (ADAR) enzymes quantified using RT-qPCR.
Main Results:
- Significantly higher A-to-I RNA editing in MED13 observed in cyanotic patients compared to acyanotic patients.
- Cyanotic patients experienced a more complicated postoperative course.
- Lower ADAR2 RNA levels were noted in cyanotic patients.
Conclusions:
- Cyanotic children exhibit elevated A-to-I RNA editing rates and more challenging surgical recoveries.
- Posttranscriptional RNA modifications may influence cellular pathways and perioperative outcomes in hypoxic conditions.
Purpose:
To test the hypothesis that RNA editing is altered in pediatric patients with cyanotic congenital heart disease (CHD) and to determine whether A-to-I RNA editing is associated with the postoperative course following cardiac surgery. Cyanotic CHD is associated with a unique pathophysiology caused by chronic hypoxia. The perioperative course of cyanotic infants is partly dictated by the degree of expression of inflammatory and cardiac genes, some of which undergo A-to-I RNA editing.
Methods:
RNA was extracted pre- and postoperatively from blood samples of cyanotic and acyanotic patients. Each sample was analyzed for A-to-I RNA editing using automatic DNA sequencing of an intronic segment of the MED13 gene. RNA expression levels of adenosine deaminase acting on RNA (ADAR) enzymes responsible for RNA editing were examined by quantitative reverse-transcriptase polymerase chain reaction.
Results:
A-to-I RNA editing in MED13 was significantly higher among cyanotic patients (n = 19) than acyanotic ones (n = 18) both pre- and postoperatively, as manifested by average editing at seven highly edited sites (27.4 ± 8.5% versus 20.8 ± 10.2%; P = 0.038) and editing at specific sites, e.g., position 14 (20.2 ± 5.1% versus 14.5 ± 5.2%; P = 0.002). Cyanotic patients exhibited a more complicated postoperative course than acyanotic patients. ADAR2 RNA levels were significantly lower among cyanotic patients.
Conclusions:
Cyanotic children manifest significantly higher rates of A-to-I RNA editing than acyanotic children as well as a more complicated surgical course. Posttranscriptional RNA changes may affect cellular and metabolic pathways and influence the perioperative course following hypoxia.
Related Concept Videos
RNA Editing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
CRISPR
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...

